Trial Phase
Trial Status
Paid Participation
Clear All
12 Apixaban Trials Near You
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerSmartwatch-Guided DOAC Therapy for Atrial Fibrillation
Trial Details
Key Eligibility Criteria
5350 Participants Needed
Trial Details
Key Eligibility Criteria
3200 Participants Needed
Trial Details
Key Eligibility Criteria
700 Participants Needed
Milvexian vs Apixaban for Atrial Fibrillation
Trial Details
Key Eligibility Criteria
20296 Participants Needed
Abelacimab vs Apixaban for Cancer-Related Blood Clots
Trial Details
Key Eligibility Criteria
1655 Participants Needed
Lambre Device for Atrial Fibrillation
Trial Details
Key Eligibility Criteria
2931 Participants Needed
Blood Thinners for Atrial Fibrillation
Trial Details
Key Eligibility Criteria
2270 Participants Needed
Rivaroxaban vs Apixaban for Blood Clots
Trial Details
Key Eligibility Criteria
2760 Participants Needed
Anticoagulation vs Thrombectomy for Pulmonary Embolism
Trial Details
Key Eligibility Criteria
100 Participants Needed
Apixaban for Inflammatory Bowel Disease
Trial Details
Key Eligibility Criteria
60 Participants Needed
DOAC vs Warfarin as Blood Thinners After Heart Surgery
Trial Details
Key Eligibility Criteria
3500 Participants Needed
Apixaban vs Enoxaparin for Bladder Cancer
Trial Details
Key Eligibility Criteria
90 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.